Correlation Between Regeneron Pharmaceuticals and Kane Biotech
Can any of the company-specific risk be diversified away by investing in both Regeneron Pharmaceuticals and Kane Biotech at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Regeneron Pharmaceuticals and Kane Biotech into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Regeneron Pharmaceuticals and Kane Biotech, you can compare the effects of market volatilities on Regeneron Pharmaceuticals and Kane Biotech and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Regeneron Pharmaceuticals with a short position of Kane Biotech. Check out your portfolio center. Please also check ongoing floating volatility patterns of Regeneron Pharmaceuticals and Kane Biotech.
Diversification Opportunities for Regeneron Pharmaceuticals and Kane Biotech
0.28 | Correlation Coefficient |
Modest diversification
The 3 months correlation between Regeneron and Kane is 0.28. Overlapping area represents the amount of risk that can be diversified away by holding Regeneron Pharmaceuticals and Kane Biotech in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Kane Biotech and Regeneron Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Regeneron Pharmaceuticals are associated (or correlated) with Kane Biotech. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Kane Biotech has no effect on the direction of Regeneron Pharmaceuticals i.e., Regeneron Pharmaceuticals and Kane Biotech go up and down completely randomly.
Pair Corralation between Regeneron Pharmaceuticals and Kane Biotech
Given the investment horizon of 90 days Regeneron Pharmaceuticals is expected to under-perform the Kane Biotech. But the stock apears to be less risky and, when comparing its historical volatility, Regeneron Pharmaceuticals is 2.85 times less risky than Kane Biotech. The stock trades about -0.18 of its potential returns per unit of risk. The Kane Biotech is currently generating about -0.05 of returns per unit of risk over similar time horizon. If you would invest 9.70 in Kane Biotech on November 2, 2024 and sell it today you would lose (1.89) from holding Kane Biotech or give up 19.48% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Very Weak |
| Accuracy | 98.36% |
| Values | Daily Returns |
Regeneron Pharmaceuticals vs. Kane Biotech
Performance |
| Timeline |
| Regeneron Pharmaceuticals |
| Kane Biotech |
Regeneron Pharmaceuticals and Kane Biotech Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Regeneron Pharmaceuticals and Kane Biotech
The main advantage of trading using opposite Regeneron Pharmaceuticals and Kane Biotech positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Regeneron Pharmaceuticals position performs unexpectedly, Kane Biotech can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Kane Biotech will offset losses from the drop in Kane Biotech's long position.| Regeneron Pharmaceuticals vs. Crispr Therapeutics AG | Regeneron Pharmaceuticals vs. Novo Nordisk AS | Regeneron Pharmaceuticals vs. Sarepta Therapeutics | Regeneron Pharmaceuticals vs. Intellia Therapeutics |
| Kane Biotech vs. Pharming Group NV | Kane Biotech vs. Health Sciences Gr | Kane Biotech vs. MedMira | Kane Biotech vs. Oxford Cannabinoid Technologies |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Share Portfolio module to track or share privately all of your investments from the convenience of any device.
Other Complementary Tools
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance |